---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-002757"
form_type: "8-K"
ticker: "SER"
cik: "0001708599"
company_name: "Serina Therapeutics, Inc."
filed_at: "2023-01-27T23:59:59+00:00"
generated_at: "2026-06-20T07:16:32.494940+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# AgeX draws remaining $500K under Secured Note, reaches $13.16M max; issues 340K warrants at $0.735

## Summary
- Borrowed final $500,000 on Jan 25, 2023, reaching the $13,160,000 maximum principal under the Secured Convertible Note with Juvenescence.
- Outstanding principal due Feb 14, 2024; interest replaced by Origination Fee of 4% per draw plus additional 4% after 12-month draw period.
- Will issue warrants for 340,136 shares of common stock at $0.735 per share to Juvenescence, subject to NYSE American listing approval.

## SEC filing metadata
- accession: 0001493152-23-002757
- form_type: 8-K
- ticker: SER
- cik: 0001708599
- company_name: Serina Therapeutics, Inc.
- filed_at: 2023-01-27T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 2.03, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1708599/000149315223002757/0001493152-23-002757-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1708599/000149315223002757/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-002757
- JSON: https://secwatch.observer/filing/0001493152-23-002757.json
- Plain text: https://secwatch.observer/filing/0001493152-23-002757.txt

## Key facts
- Debt Financings
  Serina Therapeutics, Inc. incurred convertible notes of $500,000 with Juvenescence Limited at 4% of the amount each draw of loan funds maturing February 14, 2024.
  - Instrument: convertible notes
  - Principal: $500,000
  - Counterparty: Juvenescence Limited
  - Rate: 4% of the amount each draw of loan funds
  - Maturity: February 14, 2024
  - Event: incurrence
  source text: On January 25, 2023, AgeX borrowed the remaining $500,000 under the Secured Convertible Promissory Note (the “Secured Note”) dated as of February 14, 2022 with Juvenescence Limited (“Juvenescence”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1708599/000149315223002757/0001493152-23-002757-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.